About resTORbio, Inc.

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.

At the moment the company generates 683M USD in revenues.

On its last earning announcement, the company reported a loss of -9.82$ per share.

The book value per share is 6.61$

resTORbio, Inc. website

Create a solid portfolio with ACET

Add ACET to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
683M 12.80% -58M -8.50% -346M -9.82 0.09 - 35M 6.61 - -5M -5M